Skip to search formSkip to main contentSkip to account menu

Glurenorm

Known as: Sanofi Synthelabo brand of gliquidone 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

AntidiabeticsHypoglycemic AgentsSulfonylurea Compoundsgliquidone
Beglynor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes.
Immunohistochemical localization of islets of Langerhans of streptozotocin (65 mg/kg, ip) induced diabetic + glurenorm (10 mg/kg… 
2001
2001
The effect of Glurenorm (gliquidone) on lenses and skin in experimental diabetes.
1995
1995
[The effectiveness of combined insulin and sulfonylurea in treating non-insulin dependent diabetic patients].
The effectiveness of combined therapy with insulin and sulfonylurea in non-insulin dependent diabetes mellitus (NIDDM) patients… 
1995
1995
[The use of the hypoglycemic preparation gliquidone in patients with digestive organ diseases combined with diabetes mellitus].
A peroral sugar-reducing preparation gliquidone (glurenorm) was tried in treatment of 66 patients with digestive diseases (peptic… 
1993
1993
[Use of glurenorm in patients with non-insulin-dependent diabetes mellitus and liver diseases].
Due to its pharmacokinetics, glurenorm (95% of the drug metabolite is withdrawn from the body with the bile) is widely used in… 
1993
1993
[Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
Glurenorm, a IInd generation sulfanylurea preparation, was used for a year as a sugar-reducing drug in 20 patients with non… 
1993
1993
[Glurenorm in the treatment of patients with non-insulin-dependent diabetes mellitus with diseases of the liver and bile ducts].
Glurenorm, a IInd generation sulfanylurea preparation, was used for a year as a sugar-reducing drug in 20 patients with non… 
1992
1992
[Combined therapy with insulin/gliquidone (Glurenorm) in type 2 diabetes after treatment failure using oral antidiabetic agents].
The authors evaluate treatment by a combination of insulin and gliquidone (Glurenorm) in 29 type 2 diabetics where long-term… 
1975
1975
[Pharmacokinetic behaviour of gliquidone (AR-DF 26), a new sulfonyl urea. Summary of the studies so far (author's transl)].
Pharmacokinetic studies of the new antidiabetic agent gliquidone, AR-DF 26, 1-cyclohexyl-3-((p-[2-(3,4-dihydro-7-methoxy-4,4… 
1975
1975
[Human pharmacokinetics and metabolism of 14C-labeled gliquidone (AR-DF 26)].
Investigations of pharmacokinetics and metabolism of 14C-labelled 1-cyclohexyl-3 (p-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)